Modulation of the autophagy‐lysosomal pathway and endoplasmic reticulum stress by ketone bodies in experimental models of stroke
Teresa Montiel,Juan Carlos Gómora‐García,Cristian Gerónimo‐Olvera,Yessica Heras‐Romero,Berenice N. Bernal‐Vicente,Xochitl Pérez‐Martínez,Luis B. Tovar‐y‐Romo,Lourdes Massieu
DOI: https://doi.org/10.1111/jnc.15852
2023-06-17
Journal of Neurochemistry
Abstract:We report for the first time that the protective effect of β‐hydroxybutyrate (BHB) against stroke and glucose deprivation is enantiomer selective. We discovered that D‐BHB treatment prevented the cleavage of the lysosomal membrane protein LAMP2, maintained lysosome integrity and stimulated the autophagic flux. Also, D‐BHB notably reduced the activation of the PERK and IRE1α branches of the unfolded protein response (UPR), attenuating protein synthesis inhibition and preventing endoplasmic reticulum stress. Together our results support the therapeutic use of D‐BHB treatment post‐ischemia, by preventing the loss of proteostasis through maintaining lysosome integrity, allowing functional autophagy, and attenuating UPR activation. Ischemic stroke is a leading cause of disability worldwide. There is no simple treatment to alleviate ischemic brain injury, as thrombolytic therapy is applicable within a narrow time window. During the last years, the ketogenic diet (KD) and the exogenous administration of the ketone body β‐hydroxybutyrate (BHB) have been proposed as therapeutic tools for acute neurological disorders and both can reduce ischemic brain injury. However, the mechanisms involved are not completely clear. We have previously shown that the D enantiomer of BHB stimulates the autophagic flux in cultured neurons exposed to glucose deprivation (GD) and in the brain of hypoglycemic rats. Here, we have investigated the effect of the systemic administration of D‐BHB, followed by its continuous infusion after middle cerebral artery occlusion (MCAO), on the autophagy‐lysosomal pathway and the activation of the unfolded protein response (UPR). Results show for the first time that the protective effect of BHB against MCAO injury is enantiomer selective as only D‐BHB, the physiologic enantiomer of BHB, significantly reduced brain injury. D‐BHB treatment prevented the cleavage of the lysosomal membrane protein LAMP2 and stimulated the autophagic flux in the ischemic core and the penumbra. In addition, D‐BHB notably reduced the activation of the PERK/eIF2α/ATF4 pathway of the UPR and inhibited IRE1α phosphorylation. L‐BHB showed no significant effect relative to ischemic animals. In cortical cultures under GD, D‐BHB prevented LAMP2 cleavage and decreased lysosomal number. It also abated the activation of the PERK/eIF2α/ATF4 pathway, partially sustained protein synthesis, and reduced pIRE1α. In contrast, L‐BHB showed no significant effects. Results suggest that protection elicited by D‐BHB treatment post‐ischemia prevents lysosomal rupture allowing functional autophagy, preventing the loss of proteostasis and UPR activation.
biochemistry & molecular biology,neurosciences